New eczema drug promising in early trial
(HealthDay)—An experimental drug may significantly reduce the itching and improve the appearance of moderate to severe eczema, a new, preliminary trial finds.
Mar 2, 2017
0
53
(HealthDay)—An experimental drug may significantly reduce the itching and improve the appearance of moderate to severe eczema, a new, preliminary trial finds.
Mar 2, 2017
0
53
(HealthDay)—Sufferers of severe eczema may be at greater risk for heart attack, stroke and irregular heartbeat, British researchers report.
May 24, 2018
0
24
(Medical Xpress) -- In a paper published in the American Journal of Respiratory and Critical Care Medicine, the University of Aberdeen team also found links between the rate an unborn baby grows and its chances of developing ...
Jun 29, 2011
0
0
Parasitic worms could hold the key to living longer and free of chronic disease, according to a review article published today in the open-access eLife journal.
Feb 2, 2021
0
16
Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic ...
Nov 8, 2017
0
12
(PhysOrg.com) -- Children who have eczema, particularly when occurring with hay fever, are nine times more likely to develop allergic asthma in their 40s, a new study reveals.
Apr 15, 2011
0
0
(Medical Xpress) -- Triclosan, a common antibacterial agent found in many hand soaps and other products, is known to have the added benefit of alleviating allergic skin conditions such as eczema. In a study recently published ...
Jan 6, 2012
0
0
Some children who have a common form of eczema should also be tested for allergic reactions because they may have a second allergic-type eczema, a new study suggests.
Sep 29, 2023
0
13
A decade-long study has identified the factor produced by a common species of skin bacteria that triggers eczema, in a breakthrough of our understanding of the condition.
Oct 19, 2020
0
7
(HealthDay)—A partially hydrolysed formula containing a specific mixture of oligosaccharides does not prevent eczema in high-risk infants, according to a study published online Jan. 27 in Allergy.
Feb 5, 2016
0
1